WASHINGTON and NEW YORK, March 31, 2017 /PRNewswire/ -- The Endocrine Society and Medscape announced today a new partnership that brings together the Society's expertise and Medscape's innovative, peer-to-peer digital platforms and award-winning content to provide clinicians with the latest guidance and most relevant insights on diagnosing and treating diabetes, obesity, osteoporosis, infertility, and other endocrine disorders.
The Endocrine Society is the largest organization of endocrinology professionals, including physicians, researchers, and educators. One of the Society's objectives is to share its resources with primary care clinicians to better equip them when treating patients. Medscape is the leading provider of medical news, expert perspectives and conference coverage for medical professionals and reaches the largest digital audience of primary care physicians.
"Hormonal disruptions cause conditions that affect millions of people, including diabetes, thyroid disorders, obesity, infertility, growth disorders, sleep disorders, and endocrine cancers," said Society President Henry M. Kronenberg, M.D. "Our exciting new partnership with Medscape is going to equip physicians around the world with the expert insights they need to better understand the latest medical breakthroughs and treatments for these conditions and ultimately help them provide the best care for their patients."
Through the partnership, Endocrine Society experts will work with Medscape editors to produce original features that bring the most timely and useful guidance to endocrinologists, primary care physicians, and all others who care for patients affected by endocrine disorders.
In addition, Endocrine Society experts will share and discuss compelling case studies on Medscape Consult™, Medscape's global, peer-to-peer, point-of-care digital platform. Tens of thousands of physicians have leveraged Medscape's crowdsourcing platform to compare cases, ask questions, and discuss best practices.
Medscape is also providing expanded news coverage of the Society's annual meeting, ENDO 2017, Orlando, Florida, April 1-4, 2017. ENDO is the world's premier event for endocrine practitioners, researchers, educators and students, showcasing the latest discoveries in endocrine science and medicine.
"With the diagnosis of endocrine disorders on the rise, physicians are seeking current, reliable and readily accessible recommendations that keep up with the pace of new clinical information," said Steve Zatz, MD, CEO of WebMD/Medscape. "Our new partnership with the Endocrine Society deepens our commitment to provide physicians with point-of-care guidance that is evidence-based, clinically useful and informed by leading experts in the field."
About the Endocrine Society
Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world's oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
The Society has more than 18,000 members, including scientists, physicians, educators, nurses, and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.
About Medscape and WebMD
Medscape, a subsidiary of WebMD Health Corp., is the leading source of clinical news, health information, and point-of-care tools for healthcare professionals. Medscape offers specialists, primary care physicians, and other health professionals the most robust and integrated medical information and educational tools. Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses and other educational programs for physicians, nurses, and other healthcare professionals.
WebMD Health Corp. is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers, and health plans through our public and private online portals, mobile platforms, and health-focused publications. WebMD®, Medscape®, CME Circle®, Medpulse®, eMedicine®, MedicineNet®, theheart.org®, and RxList® are among the trademarks of WebMD Health Corp. or its subsidiaries.
SOURCE Medscape; The Endocrine Society